Arsenic trioxide (As 2 O 3 ) can induce clinical remission in patients with acute promyelocytic leukemia (APL), including those who have relapsed after treatment with all-trans-retinoic acid (RA). In vitro studies with the APLderived NB4 cell line showed that As 2 O 3 exerts a dosedependent dual effect, which induces apoptosis at 1 lM, whereas at a lower concentration of 0.1 lM, a partial differentiation of APL is observed. In non-APL cells, interferon (IFN) a and 1 lM As 2 O 3 act synergistically to induce apoptosis. In this report, we show that in NB4 cells and in two RA-resistant NB4-derived cell lines, NB4-R1 and NB4-R2, IFNa or IFNc combined with 0.1 lM As 2 O 3 lead to an increased maturation effect. Moreover, IFNc alone is able to differentiate RA-sensitive and -resistant cells with a higher maturation effect on NB4-R2 cells. In contrast, all these cells underwent apoptosis in the presence of the cytokine and a higher concentration of As 2 O 3 . IFNc boosted As 2 O 3 -induced apoptosis in APL cells as tested by TUNEL, Annexin V staining and activation of caspase 3. As 2 O 3 differently altered IFNinduced gene products; it downregulated PML/RARa and PML, did not alter PKR and Stat1, and upregulated interferon regulatory family (IRF)-1. Synergism by IFNc and arsenic on IRF-1 expression is mediated by a composite element in the IRF-1 promoter that includes an IFNc-activation site (GAS) overlapped by a nonconsensus site for nuclear factor kappa B (NFjB). Arsenic has no effect on NFjB, whereas it enhances the activation of Stat1 by IFNc in NB4 cells leading to an increase in IRF-1 expression.
Introduction
All-trans-retinoic acid (RA) is a strong cyto-differentiating agent efficient in the clinical treatment of acute promyelocytic leukemia (APL), the M3 subtype in the French-American-British (FAB) classification (de The and Chelbi-Alix, 2001; Warrell et al., 1993) . APL is characterized by a blockage of granulopoiesis at the promyelocytic stage. This pathology is associated with the t(15;17) translocation that causes the fusion of the PML (Promyelocytic leukemia) with the RARa locus and expression of a PML-RARa chimeric protein in leukemic cells under the control of the PML promoter . The expression of the chimeric protein causes delocalization of PML and other components from nuclear bodies (NBs) to a microspeckled nuclear structure and alteration of RA signaling. The treatment of APL with RA results in the degradation of the chimeric protein and is paralleled by a restoration of the normal localization of PML on NBs (Dyck et al., 1994; Koken et al., 1994; Weis et al., 1994; Yoshida et al., 1996; Zhu et al., 1997) and induction of granulocytic maturation both in vivo and in vitro.
Despite the large success of RA therapy in APL, a significant percentage of patients relapse after initial remission and become resistant to RA treatment. The APL-derived cell line NB4 (Lanotte et al., 1991) and two distinct types of maturation-deficient sublines, NB4-R1 and NB4-R2, isolated from the RA-sensitive parental line (Ruchaud et al., 1994) provide tools to address the question of the molecular mechanisms underlying the RA sensitivity and resistance of APL cells. It has been shown that the basal level of RARa, RXRa and PML mRNAs and proteins were roughly the same in the three cell lines (Duprez et al., 1996) . While NB4, NB4-R1 and NB4-R2 cells express comparable amounts of PMLRARa mRNA, only NB4 and NB4-R1 cells express the chimeric protein. In NB4-R1 cells, an RA-induced PML-RARa decrease is associated with changes in surface markers, but not terminal maturation (Duprez et al., 1996) . NB4-R1 cells treated with RA fail to mature, although they respond to RA since they can be subsequently triggered to mature by an additional cAMP signal (cAMP is inactive given alone) (Duprez et al., 1996) . NB4-R2 cells were resistant to the combined RA and cAMP treatment.
Arsenic trioxide (As 2 O 3 ), a component of antileukemic drugs used in Chinese traditional medicine, was shown to be an effective treatment for APL. In a phase II study, 15 of 16 patients resistant to RA and conventional chemotherapy achieved complete remission with intravenous infusion of As 2 O 3 (Chen et al., 1997b) . As 2 O 3 , like RA, induces the PML/RARa degradation, resulting in the restoration of PML NBs (Zhu et al., 1997) . Moreover, in non-APL cells, As 2 O 3 induces PML modification by SUMO-1, accelerates the targeting of PML onto NBs and induces the degradation of the PML protein (Zhu et al., 1997) .
In vitro studies performed in freshly isolated APL blasts and in the NB4 cell line showed that As 2 O 3 exerts a dose-dependent dual effect on APL cells (Chen et al., 1997a) . As 2 O 3 induces apoptosis at 1 mM, whereas at a lower concentration of 0.1 mM, a partial differentiation of APL cells was observed. Interestingly, in non-APL cells, IFNa and As 2 O 3 act synergistically to induce apoptosis (Bazarbachi et al., 1999; El-Sabban et al., 2000) . The molecular mechanisms of the cooperative action between IFN and As 2 O 3 are not elucidated.
IFNs are a large family of multifunctional secreted proteins that regulate cellular antiviral, antitumor and immunological responses by activating the expression of IFN-stimulated genes (ISGs). IFNs are divided into two types, type I (IFNa, IFNb, IFNo and IFNt) and type 11 (IFNg).
The biological activities of IFNs are initiated by binding to their cognate receptors. After interacting with different cell surface receptors, type I and type II IFNs activate different signal cascades, known as the Jak/STAT pathways, leading to the transcription of distinct sets of genes that mediate the biological effects of these cytokines (Schindler and Darnell, 1995) .
In response to IFNa/b, Jak1 and Tyk2 phosphorylate Stat1, Stat2 and Stat3, leading to the formation of STAT homo-or heterodimers through mutual phosphotyrosine-Src homology region 2 (SH2) interactions (Schindler and Darnell, 1995; Pellegrini and DusanterFourt, 1997) . The IFNs-stimulated gene factor 3 (ISGF3) is formed by Stat1 and Stat2 (Stat1 : 2) in association with the DNA-binding protein, IRF9, a member of the interferon regulatory factor (IRF) family. ISGF3 binds to the specific DNA sequence called the IFN-stimulated response element (ISRE) present in the promoter regions of all type I ISGs. In response to IFNg, Jak1 and Jak2 phosphorylate only Stat1, and which forms homodimers that bind to the IFNgactivated site (GAS). The transcription factor, IRF-1, highly induced by IFNg because of the presence of a GAS site in its promoter, has the property of binding the ISRE, thus directly activating IFNa/b-stimulated genes. This can explain in part the complex pattern of gene expression; for example, IFNg can induce the synthesis of genes that lack GAS sites via the induction of IRF-1 (Foss and Prydz, 1999) . Characterization of these signaling pathways has provided some insights into the overlapping or synergistic effects of various IFNs.
In this report, we show that depending on the concentration of arsenic used, combined arsenic and IFN treatment enhances differentiation and apoptosis in RA-sensitive and -resistant NB4 cells. Arsenic acted synergistically with IFNg to induce apoptosis by activating caspase-3, and enhanced IRF-1 gene expression by increasing IFNg-induced Stat1 homodimer DNA-binding activity.
Materials and methods

Reagents
All-trans-RA, arsenic (As 2 O 3 ), nitroblue tetrazolium (NBT) and phorbol myristate acetate (PMA) were purchased from Sigma-Aldrich (St Louis, MO, USA). A 10 mM RA stock solution was prepared in DMSO and stored at À201C in the dark. A 100 mM stock solution of As 2 O 3 was obtained by dissolving arsenic in 1 N NaOH and diluting with H 2 O. DMEM, RPMI and fetal calf serum (FCS) were supplied by Gibco (France). Rabbit anti-PML antibodies were described previously (Daniel et al., 1993) . Rabbit polyclonal anti-Stat1 and anti-IRF-1 antibodies were obtained from Santa Cruz Biotechnology (CA, USA; anti-RAR (RPF) was kindly provided by P Chambon (Strasbourg, France); and the anti-PKR antibody was obtained from Ribogene, Inc.
Cell culture conditions
The NB4-APL cell line and the NB4-derived lines (NB4-R1 and NB4-R2) (Lanotte et al., 1991; Duprez et al., 1992) were grown in RPMI-1640 supplemented with 10% FCS as previously reported for the isolation and maintenance of the NB4 cell line.
Cell morphology and characterization of cell differentiation
Cells were harvested after different treatments. Morphology was analysed after May-Gru¨nwald-Gremsa staining of cell smears. Differentiation of NB4, NB4-R1 and NB4-R2 cells was also assessed by the ability of the cells to produce superoxide. This was measured by the degree of reduction of (NBT (Sigma-Aldrich) achieved by the cells over a 30-min period at 371C, in the presence of PMA (Miller et al., 1995) .
Apoptosis studies
The terminal deoxy-transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick end-labeling (TUNEL) assay was used to monitor the extent of DNA fragmentation due to apoptosis. The assay was performed according to the recommendations of the manufacturer (Boehringer, Mannheim, Germany). Fluorescein-conjugated dUTP incorporated in nucleotide polymers was detected and quantified using flow cytometry. For each treatment, 10 000 cells per sample were acquired and analysed using Cell-Quest software (Becton Dickinson). Results are expressed as the percentage of TUNEL-positive cells. The exposure of phosphatidyl serine (PS) was determined by the binding of FLUOS-coupled Annexin V (Boehringer Mannheim, Mannheim, Germany) according to the manufacturer's protocol. Briefly, treated cells (0.5-1.10 6 ) were washed and resuspended in a binding buffer containing Annexin V-FLUOS and propidium iodide for 10 min prior to analysis. A total of 10 000 events were collected on a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) equipped with a 488 nm argon laser, and analysed using the CellQuest software (Becton Dickinson).
Western blot analysis
Untreated and treated cells were washed in PBS and centrifuged, then the pellet was boiled for 10 min in 125 mM Tris pH 7, 1% SDS, 10% glycerol and 0.75 mM PMSF. Protein (30 mg) was analysed on a 10% SDS-PAGE gel and transferred onto nitrocellulose by semidry blotting. Membranes were blocked with 10% skimmed milk in TBS for 2 h and incubated overnight with the following specific antibodies:
anti-PML (rabbit, 1/2000), anti-RARa (rabbit, 1/4000), Stat1a (mouse, 1/1500), anti-IRF-1 (rabbit, 1/1500) or anti-PKR (mouse, 1/5000). These initial incubations were followed by incubation with anti-rabbit IgG or anti-mouse IgG horseradish peroxidase-conjugated antibodies (Biosys). Antibody complexes were detected by chemiluminescence using the ECL kit (Amersham Aylesbury, UK). The membranes were reprobed if necessary; for this, they were incubated in glycine 0.1 M pH 2.9 for 30 min, washed twice in PBS-Tween and then blocked and incubated as described. To estimate the apparent molecular mass of polypeptides, prestained molecular weight standards (BioRad laboratories, Richmond, CA, USA) were used.
Northern blot analysis
Experiments were performed during the exponential growth phase of the cells. Cells were treated with various stimuli, harvested at the times indicated and the total RNA was extracted with a Bioprobe Systems RNA extraction Kit Standard. Samples containing equal amounts of total RNA (20 mg) were size-fractionated on 1% formaldehyde-agarose gels and transferred onto nitrocellulose membranes (Scheicher and Schuell). Radiolabeled IRF-1 (Maruyama et al., 1989) and GADPH cDNA probes were prepared by random priming.
DNA constructions
The IRF-1 promoter-containing plasmid has been previously described (Pine et al., 1994 ). An EcoRI-PstI fragment, which contains the entire IRF-1 promoter, was subcloned into a HindIII site of the pZluc promoterless luciferase reporter vector. WTGAS is an oligonucleotide spanning the IRF-1 GAS and 3MGAS is an IRF-1 GAS mutant obtained by ligation of an oligonucleotide containing the AA to CC mutation at positions À115 and À116 into the HindIII site of ptkLuc as described (Pine et al., 1994) .
Transient transfection
HepG2 cells (3 Â l0 4 /ml) were seeded in six-well plates and transfected with 2 mg of plasmid DNA using the Fugene transfection reagents according to the manufacturer's protocol. Cells were also transfected with a b-galactosidase expression plasmid, which was used to normalize luciferase activity. The medium was changed 24 h later and the cells were treated with IFNg (200 U/ml), IFNa (1000 U/ml), RA (1 mM), As 2 O 3 (1 mM) or IFN-As 2 O 3 or RA-As 2 O 3 combinations. After 24 h, cells were harvested and the relative luciferase and b-galactosidase activities were measured with a luminometer. The results were normalized and expressed as the fold induction of luciferase reporter activity.
Electrophoretic mobility shift assays
Cells were treated as described in legends, harvested, washed with cold PBS and whole cell nuclear extracts were prepared (Gupta et al., 1996) . Briefly, 3 Â 10 7 cells were washed with cold PBS and lysed in 800 ml of cold freshly prepared lysis buffer (0.5% NP-40, 50 mM Tris pH 8.0, 10% glycerol, 0.1 mM EDTA, 200 mM NaCl, 1 mM DTT) completed with proteases inhibitors (Complete TM protease inhibitor cocktail, Boehringer Mannheim). Proteins (5 mg) were examined by electrophoretic mobility shift assays (EMSA) as described elsewhere (Pine et al., 1994) . Cold competitors were added in 200-fold molar excess of the radiolabeled probe. For EMSA competitions and experiments, the following double-stranded oligonucleotides were used (consensus sequences are underlined): GAS element, 5
0 -TACAACAGCCTGATTTCCCCGAAATGACG C-3 0 (Pine et al., 1994) and NFkB motif, 5 0 -TGGGCT GGGGAATCCCGCTAA-3 0 (Sims et al., 1993) . The identity of STAT-1 and NFkB in the respective complexes with the oligonucleotides was confirmed with specific antibodies, as previously described (Pine, 1997) . The anti-STAT-1 antiserum was a gift from Chris Schindler. The anti-p65 antiserum was obtained from Santa Cruz. A negative control antiserum was raised against duck metallothionein (Pine, unpublished) .
Results
As 2 O 3 (0.1 mM) acts cooperatively with IFN (a or g) to induce differentiation in NB4 and in RA-resistant NB4 cells
It has previously been shown that As 2 O 3 at a low concentration of 0.1 mM can induce some differentiation of APL cells (Chen et al., 1997a) . Since IFN can boost RA-induced cell differentiation in parental NB4 cells Chelbi-Alix and Pelicano, 1999) , we asked whether it could cooperate with As 2 O 3 to induce maturation in RA-sensitive and -resistant NB4 cells. NB-4, NB4-R1 and NB4-R2 cells were treated for 3 days with 1000 U of IFNa or IFNg per ml, 0.1 mM As 2 O 3 or their combination. At 0.1 mM, As 2 O 3 alone did not alter the growth of NB4, NB4-R1 or NB4-R2 cells. When combined with IFN (a or g), no cooperative action on the inhibition of cell growth was observed on the three cell lines (data not shown). As maturation is associated with the ability of myeloid cells to produce superoxide, NB4 and the resistant cells were examined with the NBT reduction assay (Figure 1 ). Differentiation was very slightly increased in NB4, NB4-R1 and NB4-R2 cells either by IFNa or by As 2 O 3 (Figure 1) . Surprisingly, NB4, NB4-R1 and NB4-R2 cells treated with IFNg alone show clear signs of granulocytic differentiation as measured by their increased ability to reduce NBT (Figure 1 , right panel) and by morphological changes (data not shown). This effect was observed at day 3; no maturation effect was observed before then (data not shown). Interestingly, in all these cells, a higher maturation was observed in the presence of 0.1 mM As 2 O 3 , either with IFNa or IFNg. The highest effect on maturation with the combined treatment was observed in NB4-R2 cells with IFNg and 0.1 mM As 2 O 3 . These results show that IFNg treatment induced differentiation in RA-sensitive and -resistant cell lines with a highest effect in NB4-R2 cells and that IFNa or IFNg cooperates with 0.1 mM As 2 O 3 to induce maturation in RA-sensitive and -resistant NB4 cells.
Pretreatment with IFNs (a or g) accelerated As 2 O 3 -induced apoptosis in RA-sensitive and -resistant NB4 cells
In non-APL cells, IFNa and 1 mM As 2 O 3 act synergistically to induce apoptosis (Bazarbachi et al., 1999; El-Sabban et al., 2000) . The molecular mechanisms responsible for this synergy are not known. To investigate whether this effect is also observed in APL Arsenic enhances the activation of Stat1 by IFNc MK Chelbi-alix et al cells, RA-sensitive and -resistant cells were treated with IFN (a or g), 1 mM As 2 O 3 , or their combination. We first tested the effects of these agents on cell proliferation. As 2 O 3 alone for 1 day inhibited cell proliferation by about 27%; IFNa or IFNg inhibited cell growth at day 2 by about 24%. The addition of As 2 O 3 in these cells pretreated with IFN (a or g) leads to an enhanced antiproliferative effect with an inhibition of about 75% (data not shown). The apoptotic response was assessed by the TUNEL assay and Annexin V labeling. As 2 O 3 (1 mM) induced apoptosis in RA-sensitive and -resistant NB4 cells, with a faster effect in resistant cells (Gianni et al., 1998; Figure 2a) . At 48 h of culture with As 2 O 3 , the percentage of apoptotic cells (TUNEL þ ) was 45, 66 and 80% for NB4, NB4-R1 and NB4-R2 cells, respectively (Figure 2a) , with 100% cell death at day 4 (data not shown). The optimal cooperation between IFN and As 2 O 3 in increasing apoptosis occurred in NB4, NB4-R1 and NB4-R2 cells that were preincubated with 1000 U/ml of IFN for 1 day before treatment with 1 mM As 2 O 3 for one additional day. In the three cell lines, treatment with IFNa or IFNg for 48 h did not induce apoptosis (Figure 2 ). As 2 O 3 (1 mM) administration for 24 h had no effect on NB4 cells, whereas some Figure 1 Effect of 0.1 mM As 2 O 3 , IFN or their combination on the NBT assay of NB4, NB4-R1 and NB4-R2 cells. Cells (1.5 Â 10 5 /ml) were treated for 3 days with 0.1 mM As 2 O 3 , 1000 U/ml of IFN (a or g) or their combination. As a positive control, these cells were also treated with RA for 3 days. NBT assays were performed at day 3. Each value represents the mean of three independent measurements in which the standard deviation did not exceed 4% /ml) were treated with 1 mM As 2 O 3 or 1000 U/ml of IFN (a or g), as described in Figure 2a . The extracts from untreated (c) or treated cells were analysed by Western blot with anti-caspase 3 antibodies increase in apoptosis was observed in both resistant cell lines. Interestingly, arsenic with IFNg, but not with IFNa, had a synergistic effect in inducing apoptosis in all three cell lines (Figure 2a) . At a lower concentration of 0.1 mM As 2 O 3 , no effect on apoptosis was observed with the combined treatment (data not shown). Fluorescence microscopy analysis of staining with FITC-conjugated Annexin V gave similar results: As 2 O 3 led to a small increase in apoptotic cells and again this was enhanced by the pretreatment with IFN, especially IFNg (Figure 2b ). Phosphatidyl serine exposure is an early marker of apoptosis detected by Annexin V binding to the cell surface. The Annexin V labeling, as the TUNEL labeling, was performed 24 h post-induction and was able to detect early signs of arsenic-induced apoptosis in TUNEL-negative cells, therefore partially masking the synergistic effect induced by IFNg/As treatment.
Caspase 3 is one of the key executioners of apoptosis. Extracts from NB4 cells treated as described in Figure 2a were tested for the activation of this protease. The level of caspase 3 is unaffected by IFN (a or g), As 2 O 3 (24 h) or IFNa plus As 2 O 3 , whereas it decreased in the case of treament by IFNg plus As 2 O 3 (Figure 2c ). Treatment with IFNg plus As 2 O 3 leads to the generation of caspase 3 cleavage product. Thus, IFNg boosts As 2 O 3 -induced apoptosis in APL cells as tested by TUNEL, Annexin V staining and activation of caspase 3.
Fate of IFN-induced PML/RARa and PML during 1 mM As 2 O 3 treatment in NB4 and in RA-resistant cells In NB4 cells, As 2 O 3 at 0.1 to 2 mM induces a loss of the PML/RARa protein (Chen et al., 1997a; Zhu et al., 1997) and IFN upregulates its expression Nason-Burchenal et al., 1995) . Since the expression of PML/RARa inhibits apoptosis in several systems (Salomoni and Pandolfi, 2002) , we tested whether IFN or As 2 O 3 would regulate the expression of this protein in RA-resistant NB4 cells. Cells were pretreated with IFN (a or g) or RA and subsequently treated with As 2 O 3 , as described above. Western blot analysis with anti-RARa antibodies was performed with extracts from NB4 and NB4-R1 cells (Figures 3a and b) and with anti-PML antibodies with extracts from NB4-R2 cells (Figure 3c ). As previously reported (Duprez et al., 1996) , NB4 and NB4-R1, but not NB4-R2, cells express the chimeric protein. The rationale for the use of the PML antibody for NB4-R2 analysis is based on the fact that NB4-R2 subline carries a point mutation affecting the chimaeric gene and consequently expresses an altered form of the chimeric protein depleted of the epitope recognized by anti-RARa (F-domain). This mutation, identical to the Gln411 mutation found in HL60-R, changes the amino-acid Gln903 to an in-phase stop codon, generating a truncated form of PML/ RARA, which has lost 52 amino acids at its C-terminal end (Duprez et al., 2000) .
Treatment with IFNa or IFNg upregulated the expression of PML/RARa in the three cell lines (Figure 3 ). Endogenous and IFN-induced PML/RARa (Figures 3a-c) and PML (Figure 3c ) proteins were totally downregulated in all three cell lines in the presence of arsenic. Under the same conditions, the expression of the IFN-induced and NB-associated Sp100 was not altered by As 2 O 3 (data not shown). This suggests that As 2 O 3 led to selective degradation of the IFN-induced PML/RARa and PML proteins.
As 2 O 3 increased IFN-induced IRF-1 at mRNA and protein levels in NB4 and in RA-resistant cells without affecting Stat1 and PKR expression We next investigated whether As 2 O 3 could modulate the expression of other key gene products involved in IFNinduced apoptosis, such as the double-stranded RNAactivated protein kinase, PKR, the signal transducer and activator of transcription, Stat1, and the interferon regulatory factor-1, IRF-1. The blots from Figure 3 were stripped and analysed with the cognate antibodies (Figure 4a) . A comparable reaction with anti-actin antibody demonstrated that equal amounts of protein were analysed. Stat1 was not induced by RA, As 2 O 3 or their combination in any of the cell lines. It was induced by IFNa and to a greater extent by IFNg in all three cell lines; however, the induction was unaffected by As 2 O 3 . As 2 O 3 alone had no effect on PKR or IRF-1 expression, whereas, as reported previously, RA increased PKR expression in NB4 and not in RA-resistant cells and it upregulated IRF-1 expression in all three cell lines, but to a lesser extent in the resistant cells ((Pelicano et al., Figure 3 Analysis of PML/RARa, RARa and PML protein levels in NB4, NB4-R1 and NB4-R2 cells. Cells (2 Â 10 5 /ml) were treated with 1 mM As 2 O 3 , 1mM RA or 1000 U/ml of IFN (a or g), as described in Figure 2a (Figure 4a) . A low and a high increase in IRF-1 expression was observed after IFNa and IFNg treatments, respectively, consistent with the presence of a GAS motif in IRF-1 promoter (Pine et al., 1994) . Interestingly, in the three cell lines, As 2 O 3 treatment enhanced IFN-induced IRF-1, slightly in the case of IFNa and highly in the case of IFNg (Figure 4a ). The capacity of arsenic to increase IFNg-induced IRF-1 expression is observed at 1 mM (Figure 4a ) and 0.1 mM (Figure 4b ). This agent did not alter the RA-induced IRF-1 expression (Figure 4a) .
To determine whether the synergistic action on IRF-1 expression by the combination of IFNg and arsenic is also observed in other cell lines lacking the (t15; 17) translocation, HepG2 cells were treated as described in Figure 2a and analysed for IRF-1 expression. Arsenic increased IFNg-induced IRF-1 protein in HepG2 cells (Figure 4c ), demonstrating that this effect is observed in APL and non-APL cells.
Arsenic cooperates with IFNg at a transcriptional level
In order to determine if As 2 O 3 acts on IFN-induced IRF-1 at the mRNA level, total RNA was isolated from NB4 cells treated with IFNg in the presence or absence of As 2 O 3 . An increase in IRF-1 mRNA was observed after IFNg treatment and this was enhanced by the addition of As 2 O 3 (Figure 5a ).
To test whether the effect of As 2 O 3 on IFN induction of the IRF-1 gene was transcriptionally regulated, we examined the activity of IRF-1 promoter sequences (EcoR1-PstI) in transfected cells. Since we did not succeed in transfecting NB4 cells, we used HepG2 because we have previously shown that these cells transfected with IRF-1 promoter responded to IFN (Pelicano et al., 1997) . Moreover, the regulation of IRF-1 protein expression by these stimuli was similar in NB4 and HepG2 cells (Figure 4 and data not shown). Transfected HepG2 cells were treated with As 2 O 3 , IFNg, IFNa or combinations (IFNa and As 2 O 3 , IFNg and As 2 O 3 ). We also tested the effect of As 2 O 3 on the previously shown twofold induction of the IRF-1 promoter by RA (Pelicano et al., 1997) . A 10-versus threefold induction of this promoter by IFNg was observed in the presence and absence of As 2 O 3 , respectively (Figure 5b ). Arsenic caused a small increase in the response to IFNa and seemed to have no cooperative effect when combined with RA.
Arsenic enhances IFNg-induced IRF-1 expression through the GAS/kB motif
To determine whether arsenic could enhance the IRF-1 gene promoter through the GAS/kB element, the EcoR1-Pst1 reporter was compared with plasmids that contained a short oligonucleotide, including either a wild-type (WTGAS) or mutated (3MGAS) GAS/kB element, linked to a minimal promoter from the HSV-1 thymidine kinase gene and a luciferase /ml) were treated with 1 mM As 2 O 3 (24 h) or 1000 U/ml of IFNg for 48 h. For the combined As 2 O 3 and IFNg treatment, cells were incubated with IFN for 24 h, then As 2 O 3 was added and incubation was continued for another 24 h. The cell extracts were analysed by Western blot with anti-IRF-1 antibodies reporter (Pine et al., 1994) . Transfected HepG2 cells were treated for 24 h with arsenic (1 mM), IFNg (200 U/ml) or both agents. Arsenic alone had little or no effect on any of these reporters, while as reported previously (Pine et al., 1994) , IFNg caused an induction with the WTGAS, but not the 3MGAS sequence. Arsenic, at a concentration of 0.1 or 1 mM, enhanced the IFNg-induced activity of the EcoR1-Pst1 and WTGAS reporters similarly (Figure 5c and data not shown), while the 3MGAS reporter remained unresponsive to IFNg in the presence of arsenic. These results do not address whether other elements in the IRF-1 promoter may also influence the effect of arsenic on response to IFNg, but do suggest that the GAS/kB element will mediate the effect in the context of the intact promoter.
Arsenic has no effect on NFkB, whereas it enhances the activation of Stat1 by IFNg in NB4 cells
To determine whether arsenic could modify IFNinduced biological responses in NB4 cells through the Stat1 and/or NFkB pathways, we studied the effect of arsenic on Stat1 and NFkB activation. Using an EMSA, we examined the ability of arsenic to affect Stat1 DNAbinding activity with an oligonucleotide that includes the GAS/kB element of the IRF-1 promoter. Extracts prepared from NB4 cells that had been pretreated for different times with arsenic prior to incubation in the absence or presence of IFNg were assayed. As shown in Figure 6 , treatment with arsenic alone never led to the activation of Stat1 DNA-binding activity. Extracts from cells treated with IFNg for 15 min formed the Stat1/ GAS complex; it did not form when a 200-fold molar excess of the unlabeled oligonucleotide was present in the assay. Interestingly, arsenic pretreatment for 16 or 24 h significantly augmented Stat1 DNA-binding activity in response to IFNg in NB4 cells. The effect of arsenic on NFkB activation was tested by EMSA performed with an oligonucleotide that included the proximal consensus NFkB binding site found in the IRF-1 promoter. Extracts from NB4 cells pretreated or not with arsenic prior to stimulation with IFN or RA were used to analyse the transcription factor binding to this region. The formation of complexes that include NFkB p50 and p65, detectable in extracts from untreated cells, was unaffected by IFN (a or g) and/or arsenic treatment. In contrast, in the extracts of RA-treated NB4 cells, the formation of these complexes increased greatly (Percario et al., 1999;  Figure 6 ). In addition, NFkB activation by RA is similar in the absence or presence of arsenic. The specificity of complex formation was confirmed by a competition experiment performed in the presence of 200-fold molar excess of the unlabeled oligonucleotide. Thus, the increase in IFNg-induced expression of IRF-1 caused by arsenic correlates with the increased activation of Stat1 and seems to be independent of NFkB. The identity of the induced Stat1 and NFkB observed in cells stimulated by IFNg or RA was confirmed by the reaction with specific antibodies (Figure 6c ).
Discussion
Arsenic has been identified as an alternative therapy in patients with both RA-sensitive and -resistant APL. At and RA on the IRF1 promoter. HepG2 cells were seeded in six-well plates and transfected with 2 mg of pIRF-1 (EcoRI-PstI) plasmid using the Fugene transfection reagent according to the manufacturer's protocol. Cells were also transfected with b-galactosidase expression plasmid, which was used to normalize luciferase activity. The medium was changed 24 h later and cells were treated for 30 h with IFNg (200 U/ml), IFNa (1000 U/ml), RA (1 mM), As 2 O 3 (1 mM) or IFN-As 2 O 3 or RA-As 2 O 3 combinations. Luciferase and bgalactosidase activities were measured as described in Materials and methods. Each experiment included triplicate transfection. The results are expressed as fold induction of luciferase reporter activity, with standard deviation indicated. (c) Arsenic increased IFNg-induced GAS/kB IRF-1 promoter activity. HepG2 cells were transfected with 3 mg of pIRF-1 (EcoR1-PstI), WTGAS and 3MGAS plasmids. In each case, pCMV b-galactosidase was used to monitor transfection efficiency. After 12 h, the medium was changed and the cells were treated with 1 mM As 2 O 3 , 200 U/ml of IFNg or their combination. All cells were harvested 48 h posttransfection. Luciferase activities were measured. The graphs show the fold luciferase activities exhibited by the reporter construct under different treatment conditions. The data represent the average calculated from triplicates of two independent experiments and are expressed as fold induction, with standard deviation indicated the cellular level, As 2 O 3 triggers apoptosis and a partial differentiation of APL cells in a dose-dependent manner; both effects are observed among patients with APL (Chen et al., 1997b) . We tested its effect in combination with IFNa or IFNg in vitro on both RAsensitive and -resistant NB4 subclones. In this report, we show that IFNa alone has negligible differentiationinducing capacity in RA-sensitive and -resistant NB4 cells. In contrast, IFNg treatment induced differentiation in RA-sensitive and -resistant cell lines with a highest effect in NB4-R2 cells, suggesting that IFNg, compared to IFNa, was more effective in promoting the maturation of APL cells. Either with IFNa or IFNg, an enhanced differentiation in combination with RA was observed in RA-sensitive, but not in RA-resistant NB4 cells and data not shown), whereas combination with a low concentration of 0.1 mM As 2 O 3 leads to a higher maturation in all three cells lines. The mechanism of arsenic-mediated differentiation is still unclear, although some results obtained in vitro, focusing on the effects of combination of arsenic and other agents such RA (Gianni et al., 1998) , cAMP (Zhu and 24 h, were treated or not with 1000 U/ml IFNg for 2 h. Nuclear extracts were prepared, adjusted to equal protein concentration and analysed by EMSA with an IRF-1 GAS probe. (b) NB4 cells were treated with 1 mM As, 1 mM RA, 1000 U/ml IFNa and/or 1000 U/ml IFNg. Reagents were added at various times prior to harvest to achieve the following single or dual treatments. As treatment alone was carried out for 48 h (lanes 3 and 4). As treatment in combination with another reagent was carried out for 24 h (lanes 7, 8, 11, 12 and 15-20) . RA, IFNa, and IFNg treatments started prior to As treatment were carried out for 48 h (lanes 5-16). IFNg treatment started after As treatment was carried out for 2 h (lanes 19 and 20). Nuclear extracts were prepared, adjusted to equal protein concentration and analysed by EMSA, with a labeled oligonucleotide representing the proximal consensus NFkB site found in the IRF-1 promoter. (c) (left panel) A GAS probe was used to assay Stat1 DNA-binding activity in extracts from cells treated for 2 h with IFNg. The reactions included rabbit polyclonal antiserum, either against an irrelevant antigen as a negative control (À) or against Stat1. The indicated Stat1 band had the same mobility as the Stat1 band in Figure 6a . (Right panel) An NFkB probe was used to assay the NFkB DNA-binding activity in extracts from cells treated with RA for 48 h. The reactions included rabbit polyclonal antiserum, either against an irrelevant antigen as a negative control (À) or against p65. The two lower NFkB bands had the same mobility as the NFkB bands in Figure 6b , and an additional slower mobility band was detected in this extract et al., 2002) or IFN (this study), suggest that the higher differentiation of APL cells results from the action of distinct signaling pathways.
Arsenic might be useful in treating patients with myeloma, myelodysplastic syndrome, T-cell prolymphocytic leukemia or ATL. ATL is triggered by human T-cell prolymphocytic leukemia virus type I infection and the viral transactivator Tax is known to play a critical role in viral transformation through alteration of the NFkB pathway. Arsenic acts in combination with IFNa to induce degradation of Tax, leading to growth arrest and apoptosis (El-Sabban et al., 2000) . Interestingly, cell-pretreatment with IFN accelerated As 2 O 3 -induced apoptosis in NB4, NB4-R1 and NB4-R2, with a synergistic effect with IFNg on caspase 3 activation (this paper).
Some IFN-regulated genes have been found to be involved in apoptosis. The NBs-associated proteins have growth-suppressive and proapoptotic properties (Salomoni and Pandolfi, 2002) . The analysis of PMLÀ/À mice and cells shows that they are protected from Fas-, TNF-and IFN-dependent apoptotic stimuli by a mechanism that involves insufficient caspase-1 and -3 activation (Wang et al., 1998) .
Another IFN-regulated gene, previously implicated in mediating the antiproliferative effects of IFN, PKR, has been reported to be a regulator of apoptosis (Gil and Esteban, 2000) . Also, IRF-1 displays some features of tumor-suppressive activity (Taniguchi et al., 1997; Taniguchi et al., 2001 ) and has been found to be required for the induction of apoptosis following DNA damage (Tamura et al., 1995) . Moreover, overexpression of IRF-1 results in the transcriptional activation of the ICE gene, and thus enhances the sensitivity of cells to radiation-induced apoptosis.
In NB4 cells, the expression of the IFN-induced PKR, Stat1, PML and IRF-1 was differently modulated by the addition of As 2 O 3 : PKR and Stat1 protein expressions were not altered, PML and PML/RARa were degraded and IRF-1 expression was upregulated. This drug alone had no effect on IRF-1 expression; however, it increased IFN-induced IRF-1 expression at the protein and mRNA levels. In addition, arsenic and IFNg acted synergistically to induce IRF-1 in APL and non-APL cells.
IRF-1 is expressed at low levels in unstimulated cells, but is induced by many cytokines such as IFNs, TNFa, IL1, IL6 and LIF and by RA or viral infections (Pine et al., 1994; Pelicano et al., 1997; Pine, 1997) . The analysis of the IRF-1 promoter region revealed that this induction is mediated by Stat1 and NFkB transcription factors through binding sites that include a GAS overlapped by a nonconsensus NFkB site and by a separate NFkB consensus site (Sims et al., 1993; Pine et al., 1994; Ohmori et al., 1997; Pine, 1997) . In fact, IFN-induced expression of IRF-1 mRNA was completely abolished in Stat1-deficient cells. IFNg and RA or IFNg and TNF synergistically increase IRF-1 gene expression through the activation of Stat1 and NFkB transcription factors respectively (Ohmori et al., 1997; Pelicano et al., 1997; Pine, 1997; Percario et al., 1999) . In this report, we show that arsenic has no effect on NFkB, whereas it enhances the activation of Stat1 by IFNg in NB4 cells and leads to a greater increase in IRF-1 expression induced by IFNg. This increase in IRF-1 without an increase in NFkB is consistent with the increased apoptosis that occurs due to treatment with IFNg plus As 2 O 3 . Stat1 is the primary DNA-binding protein for response to IFNg, but not IFNa. The increase in IFNg-induced Stat1 activation by arsenic leads to a higher level of the biological activities induced by this cytokine. IRF-1 has been implicated in the regulation of apoptosis and seems to have a potential suppressor-like function. Clinical studies have also indicated that the loss of IRF-1 may affect the development of some forms of human leukemia (Kroger et al., 2002) .
It would be interesting to examine whether treating APL patients with As 2 O 3 plus IFNg could increase the proportion of cells undergoing differentiation or apoptosis and thereby enhance chemotherapeutic response.
Abbreviations
IFN, Interferon; Arsenic, As 2 O 3 in the text and As in the figures; PML, pro-myelocytic leukemia-related gene/ protein; APL, acute promyelocyic leukemia, RARa, retinoic acid receptor a; RA, retinoic acid; NBs, nuclear bodies; ISG, IFN-stimulated gene; Stat, signal transducers and activators of transcription; IRF, interferon regulatory factor (IRF); ISGF3, IFN-stimulated gene factor 3; ISRE, IFN-stimulated response element; GAS, IFNg-activated site; PKR, RNA-dependent protein kinase.
